Research
Read how they describe their research on their University of Ottawa profile.
Latest funding
- $100,000
Dapagliflozin for Long COVID Syndrome
CIHR · 2023 · Co-investigator
- $2,500,000
Imaging Modalities to Assist with Guiding Therapy and the Evaluation of Patients with Heart Failure (IMAGE-HF)
CIHR · 2009 · Co-investigator
No publications available.
Dapagliflozin for Long COVID Syndrome
Principal investigators: Paterson, Ian; Thompson, Richard B
Keywords: Cardiometabolic Diseases; Long Covid
Imaging Modalities to Assist with Guiding Therapy and the Evaluation of Patients with Heart Failure (IMAGE-HF)
Principal investigators: Beanlands, Rob; Arnold, J. Malcolm O; Friedrich, Matthias G; Knuuti, Juhani; Tardif, Jean-Claude; Wells, George A; Wright, Graham A; Yla-Herttuala, Seppo
Keywords: Animal Models; Cardiac Imaging; Clinical Evaluation; Heart Failure; Image Technology Standardization; Imaging Biomarker Development
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.